Effect of tissue processing on assessment of endoscopic intestinal biopsies in dogs and cats

Journal of Veterinary Internal Medicine

Volumn 24, Issue 1, 2010, Pages 84-89

  Willard, M D ^a   Moore, G E ^b   Denton, B D ^b   Day, M J ^c   Mansell, J ^a   Bilzer, T ^d   Wilcock, B ^e   Gualtieri, M ^f   Olivero, D ^f   Lecoindre, P ^g   Twedt, D C ^h   Collett, M G ⁱ   Hall, E J ^c   Jergens, A E ^j   Simpson, J W ^k   Else, R W ^k   Washabau, R J ^l  

^a TEXAS A AND M UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e Histovet   (Canada)

^f UNIVERSITY OF MILAN   (Italy)

^g CLINIQUE VÉTÉRINAIRE   (France)

^h Department of Environmental and Radiological Health Sciences   (United States)

ⁱ MASSEY UNIVERSITY   (New Zealand)

^j IOWA STATE UNIVERSITY   (United States)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

^l UNIVERSITY OF MINNESOTA   (United States)

more..

Author keywords

Histology; Inflammatory bowel disease; Protein losing enteropathy

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOPSY; CAT; CAT DISEASE; DOG; DOG DISEASE; ENDOSCOPY; GASTROINTESTINAL DISEASE; LABORATORY DIAGNOSIS; PATHOLOGY;

ANIMALS; BIOPSY; CAT DISEASES; CATS; DOG DISEASES; DOGS; ENDOSCOPY; GASTROINTESTINAL DISEASES; SPECIMEN HANDLING;

ANIMALIA; CANIS FAMILIARIS;

EID: 73349092783     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2009.0432.x     Document Type: Article

References (23)

1. Schreiner N, Gaschen F, Grone A, et al. Clinical signs, histol-ogy and CD-3 positive cells before and after treatment of dogs with chronic enteropathies. J Vet Int Med 2008;22:1079-1083.
2. Allenspach K, Wieland B, Grone A, et al. Chronic entero-pathies in dogs: Evaluation of risk factors for negative outcome. J Vet Int Med 2007;21:700-708.
3. McCann T, Ridyard A, Else R, et al. Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel dis-ease. J Small Anim Pract 2007;48:619-624.
4. Craven M, Simpson J, Ridyard A, et al. Canine inflammatory bowel disease: Retrospective analysis of diagnosis and outcome in 80 cases (1995-2002). J Small Anim Pract 2004;45:336-342.
5. Garcia-Sancho M, Rodriguez-Franco F, Sainz A, et al. Eval-uation of clinical, macroscopic, and histopathologic response to treatment in nonhypoproteinemic dogs with lymphocytic-plasmacy-tic enteritis. J Vet Int Med 2007;21:11-17.
6. Jergens AE, Schreiner CA, Frank DE, et al. A scoring index for disease activity in canine inflammatory bowel disease. J Vet Int Med 2003;17:291-297.
7. Munster M, Horauf A, Bilzer T. Bestimmung des Krankheits-schweregrades und des Ergebnisses diatetischer, antibiotischer und immunsuppressiver Interventionen durch anwendung des caninen IBD Aktivitatsindex bei 21 Hunden mit chronisch entzundlicher Darmkrankheit. Tierarztl Prax 2006;119:493-505.
8. Zentek J, Hall EJ, German A, et al. Morphology and immunopathology of the small and large intestine in dogs with non-specific dietary sensitivity. J Nutr 2002;132:1652S-1654S.
9. Stonehewer J, Simpson JW, Else RW, et al. Evaluation of B and T lymphocytes and plasma cells in colonic mucosa from healthy dogs and from dogs with inflammatory bowel disease. Res Vet Sci 1998;65:59-63.
10. Janeczko S, Atwater D, Bogel E, et al. The relationship of mucosal bacteria to duodenal histopathology cytokine mRNA and clinical disease activity in cats with inflammatory bowel disease. Vet Microbiol 2008;128:178-193.
11. Willard MD, Jergens AE, Duncan RB, et al. Inter-observer variation among histopathologic evaluations of intestinal tissues from dogs and cats. J Am Vet Med Assoc 2002;220: 1177-1182.
12. Rodriguez-Franco F, Sainz A, Tesouro MA, et al. Pharma-cological and dietary treatment of canine malabsorption syndrome: A retrospective study of 17 clinical cases. Zentralbl Veterinarmed A 1999;46:439-452.
13. Littman MP, Dambach DM, Vaden SL, et al. Familial protein-losing enteropathy and protein-losing nephropathy in Soft Coated Wheaten Terriers: 222 cases (1983-1997). J Vet Int Med 2000;14:68-80.
14. Murphy K, German A, Ruaux C, et al. Fecal alpha1-prote-ase inhibitor concentration in dogs with chronic gastrointestinal disease. Vet Clin Pathol 2003;32:67-72.
15. Willard MD, Helman G, Fradkin JM, et al. Intestinal crypt lesions associated with protein-losing enteropathy in the dog. J Vet Int Med 2000;14:298-307.
16. Willard MD, Zenger E, Mansell JL. Protein-losing enteropathy associated with cystic mucoid changes in the intestinal crypts of two dogs. J Am Anim Hosp Assoc 2003;39:187-191.
17. Ross LA, Lamb CR, Jakowski RM. Cystic mucinous enteropathy in a dog. J Am Anim Hosp Assoc 1990;26:93-96.
18. Day MJ, Bilzer T, Mansell J, et al. Histopathologic stan-dards for the diagnosis of gastrointestinal inflammation in endoscopic biopsies from the dog and cat: A report from the World Small Animal Veterinary Association Gastrointestinal Standardiza-tion Group. J Comp Path 2008;138:S1-S43.
19. Byrt T. How good is that agreement?. Epidemiology 1996;7:561.
20. Berghoff N, Ruaux C, Steiner J, et al. Gastroenteropathy in Norwegian Lundehund. Compend Cont Educ 2007;29:456-472.
21. Vaden SL, Sellon RK, Melgarejo LT, et al. Evaluation of intestinal permeability and gluten sensitivity in Soft-Coated Wheaten Terriers with familial protein-losing enteropathy, protein-losing nephropathy, or both. Am J Vet Res 2000;61:518-524.
22. United Kingdom National External Quality Assessment Service. Available at http://www.ukneqas.org.uk. Accessed January 14,2008.
23. Kull PA, Hess RS, Craig LE, et al. Clinical, clinicopatholog-ic, radiographic, and ultrasonographic characteristics of intestinal lymphangiectasia in dogs: 17 cases (1996-1998). J Am Vet Med Assoc 2001;219:197-202.